In colorectal cancer, CIMP is linked to the BRAFV600E mutation and to microsatellite instability [43], while another alternative CIMP, driven by KRAS mutation(+), has been reported in colorectal cancer and linked to adverse patient prognosis [43–45]. Here, KRAS is linked to colorectal cancer.